Disclosed is a human monoclonal antibody directed against influenza A virus hemagglutinin antigen, wherein the antibody is capable of binding to and neutralizing a plurality of subtypes of the influenza A virus, wherein said plurality of subtypes comprises at least one influenza A virus subtype containing hemagglutinin H1 and at least one influenza A virus subtype containing hemagglutinin H3.